POSB108 Cost-Effectiveness and Cost-Utility Analyses of Atezolizumab-Based Therapy in Patients with Advanced or Unresectable Hepatocellular Carcinoma in Italy
Abstract
Authors
L Pradelli M Bellone J Sanchez Alvarez M Leibfried A Caputo